[:en]Identification of regulatory science priorities for 2018.
Building 31, Room 1503A (Great Room)
FDA wants your input. Submit electronic or written requests to make oral presentations no later than April 5, 2017. Electronic or written comments will be accepted at any time until the docket closes on June 2, 2017. You may also submit ideas on generic drug research topics to be included on the FY 2018 Regulatory Science Plan by emailing GDUFARegulatoryScience@fda.hhs.gov. FDA will do its best to accommodate requests to make public comments.
If you wish to attend (either in person or by Webcast), please email to GDUFARegulatoryScience@fda.hhs.gov by April 5, 2017. The email should contain complete contact information for each attendee (i.e., name, title, affiliation, address, email address, telephone number and whether you will be attending in person or by webcast).
Information on previous public meetings can be found on the GDUFA Regulatory Science website (see "Part 15 Public Meetings").
www.fda.gov/Drugs/NewsEvents/ucm527823[:]
